Edition:
United States

Insider Trading: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

214.78USD
17 Jan 2017
Change (% chg)

$-1.36 (-0.63%)
Prev Close
$216.14
Open
$214.40
Day's High
$215.83
Day's Low
$211.51
Volume
955,763
Avg. Vol
1,085,153
52-wk High
$301.98
52-wk Low
$184.58

MCDONNELL PETER J
Trading Date Type Shares Traded Price Shares Held
7 Aug 2016 Buy 201 $248.31 4,280
4 May 2016 Buy 1,188 $210.34 4,079
4 Jun 2015 Buy 826 $302.30 2,891
16 Mar 2015 Buy 2,065 $0.00 2,065

Institutional Holders

% Shares Owned: 89.51%
# of Holders: 1,533
Total Shares Held: 335,720,120
3 Mo. Net Change: -277,393
# New Positions: 19
# Closed Positions: 12
# Increased Positions: 66
# Reduced Positions: 73
# Net Buyers: -7

Officers & Directors

Name Age Since Current Position

Brenton Saunders

46 2016 Chairman of the Board, President, Chief Executive Officer

Maria Hilado

51 2014 Chief Financial Officer, Executive Vice President

Karen Ling

52 2014 Chief Human Resource Officer, Executive Vice President

A. Robert Bailey

52 2014 Executive Vice President, Chief Legal Officer and Corporate Secretary

William Meury

47 2015 Executive Vice President and President, Branded Pharma

Paul Navarre

46 2015 Executive Vice President and President, International Brands

Philippe Schaison

54 2015 Executive Vice President and President, Allergan Medical

Robert Stewart

48 2015 Executive Vice President and President, Generic and Global Operations

James D'Arecca

45 2013 Chief Accounting Officer

Christopher Coughlin

63 2016 Lead Independent Director

Paul Bisaro

55 2016 Director

Nesli Basgoz

58 2014 Independent Director

James Bloem

65 2013 Independent Director

Christopher Bodine

60 2013 Independent Director

Michael Gallagher

70 2015 Independent Director

Catherine Klema

57 2016 Independent Director

Peter McDonnell

57 2015 Independent Director

Patrick O'Sullivan

74 2013 Independent Director

Ronald Taylor

68 2013 Independent Director

Fred Weiss

74 2013 Independent Director